A rapid and sensitive high-performance liquid chromatography-mass spectrometry method was established to determine the trace residues of piperazine in vortioxetine hydrobromide. The presence of piperazine was determined by precolumn derivatization with dansyl chloride. Chromatographic separation was performed on a Waters SunFire C8 column (150 × 4.6 mm, 3.5 μm) in gradient elution mode, using formic acid and acetonitrile as mobile phase. Detection was performed in a single quadrupole mass spectrometer in single ion monitoring mode using positive ionization. An m/z value of 553 was selected for monitoring disubstituted piperazine by DNS-Cl. Linearity, accuracy, and precision were found to be acceptable over the piperazine concentration range of 0.3525 -2.35 ng mL -1
Introduction
Phosphate and citrate salts of piperazine are effective treatments for roundworm and pinworm Conners. 1 Currently, piperazine is widely used as a drug intermediate to synthesize vortioxetine hydrobromide (VT) and other drugs. [2] [3] [4] VT was jointly developed by the pharmaceutical companies Lundbeck A/S and Takeda Pharmaceutical Company Ltd. to treat major depressive disorders. [5] [6] [7] Piperazine is used as a starting material in the synthesis of VT and may represent a residual compound in the active pharmaceutical ingredient (API) product.
Thus, the determination of piperazine is of critical importance for the quality control of VT, according to the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Q3a guidelines (Impurities in New Drug Substances). 8 Meanwhile, piperazine was reported in the Carcinogenic Potency Database (CPDB) as one of 1547 chemicals that can cause cancer (ID:1145), and the ICH indicates that such compounds must be rigidly controlled for their residual volume in drugs. 9 For a mutagenic impurity, a Threshold of Toxicological Concern (TTC) value of 1.5 μg per person per day is considered to be associated with negligible risk and can be used as a default value for most pharmaceuticals to derive an acceptable limit. 10 From this calculation, for a 20 mg daily dose of vortioxetine excluded hydrobromide, the final acceptable residual limit of piperazine in VT is 59 μg g -1 . 11 A detection method with high sensitivity and selectivity is thus required for such low permissible residue limits.
The determination of piperazine presents some challenges because of its high polarity and weak ultraviolet (UV) absorbance. To date, several methods have been used for the determination of piperazine, such as colorimetric analysis, non-aqueous titration, gas chromatography (GC), liquid chromatography (LC), capillary electrophoresis (CE), and LC-mass spectrometry (LC-MS).
The specificities of colorimetric analysis were inadequate, as similar chemical structures interfere with determinations. 12 LC is relatively straightforward to use for the determination of piperazine and can accurately separate the degradation products. However, the absorption of piperazine is particularly weak in the UV visible region, meaning that it cannot be detected directly using a UV or fluorescence detector and must instead be detected after derivatization. 13 Alternatively, piperazine can be detected directly without the need for derivatization through non-UV detectors, such as CE coupled with benzylamine as the UV absorbing probe, high performance LC (HPLC)-evaporative light scattering detector (ELSD), or GC. [14] [15] [16] The limits of detection as reported in the literature, are unsuitable for the determination of trace residues. 14, 16, 17 The separation of highly polar basic piperazine is usually performed using HPLC coupled with precolumn derivatization, with MS, tandem MS or fluorescence used as a detector. 13, 17, 18 Dansyl chloride (DNS-Cl), 1,2-phthalic dicarboxaldehyde, and benzene sulfonyl chloride are commonly used as derivative reagents. Several different separation column mechanisms have been previously used to separate piperazine and co-eluates, such as hydrophilic interaction chromatography (HILIC) mode on a cyanopropyl (CN) bonded stationary phase, 14 reversed phase chromatography on octadecyl silane (C18), or a mixed-mode stationary phase such as SG-MIX. 17 Both HILIC and SG-MIX phase represent a mixed-mode bonded column method. HILIC has been widely used for the analysis of polar compounds, including sugars, natural products, and drugs. [19] [20] [21] [22] [23] [24] However, the solubility of polar compounds is limited in the high concentration organic solvents typically used in the initial mobile phase of HILIC. Furthermore, the mixed-mode bonded column life deteriorates rapidly due to its high attrition rate of packing. C18 is a choice for the separation of piperazine with precolumn derivatization. 13, 18 The original co-eluates, however, may be more strongly retained (or even become difficult to elute) due to derivatization. As the C8 ligand is less hydrophobic, there was less retention compared with the C18 ligand. Therefore, under reversed-phase chromatographic conditions, the analytes are eluted more easily on the C8 column, 25, 26 which may shorten the analysis time in some cases.
Therefore, in this study, a C8 column was used as a separation carrier, MS was used as the detector, and DNS-Cl was used as a precolumn derivatization reagent, with the aim of developing a highly sensitive LC-MS method coupled with precolumn derivatization using DNS-Cl to quantify piperazine trace residues in VT. The total run time on the C8 column was 10 min. The piperazine in the presence of DNS-Cl disubstituted derivative (DNS-piperazine-DNS) was investigated. Based on the validation data, the LC-MS method developed was considered suitable for the quantitation of piperazine residues in VT.
Experimental

Chemicals and reagents
HPLC grade acetonitrile and LC-MS grade methanol were purchased from Merck (Darmstadt, Germany). LC-MS-grade formic acid was obtained from Fluka (Sigma-Aldrich, St. Louis, MO, USA). DNS-Cl (97%) was purchased from Alfa Aesar (Tianjin, China). Milli-Q water was of ultra-pure quality (>18 MΩ cm -1 ) and prepared in-house. Nitrogen (99.999%) was purchased from Shengtang (Tianjin, China). Anhydrous piperazine was purchased from Runjie (Shanghai, China). VT was a gift sample from Jiangsu Deyuan Pharmaceutical Co., Ltd (Lianyungang, China).
Sodium carbonate and sodium bicarbonate of analytical grade were purchased from Guangfu (Tianjin, China).
Chromatographic systems and conditions
The LC-MS system consisted of an Agilent 1260 module with a G1379B 1260 u-Degasser, G1312B 1260 Bin Pump system, G1316C 1290 TCC column oven, and a G4212B 1260 DAD detector connected to an Agilent 6130 MSD mass spectrometer. The system was operated using Agilent ChemStation software (Santa Clara, CA, USA). Chromatography was performed using a 3.5-μm 110A, 150 × 4.6 mm (i.d.) C8 column (Waters SunFire, Milford, MA, USA). The LC system was operated in gradient mode with a flow rate of 1 mL/min. Solvent A consisted of water with 0.1% formic acid, and solvent B consisted of acetonitrile with 0.1% formic acid. The linear gradient started at 70% solvent B and increased to 100% solvent B within 7 min. Over the following 3 min, solvent B was maintained at 100%. Starting conditions were achieved in 1 min, and the column was re-equilibrated for 6 min. The injection volume was 10 μL, and the column oven temperature was 35 C. The total run time was 10 min.
In the mass spectrometer, positive electrospray ionization (ESI) was used. Data acquisition was carried out in single ion monitoring (SIM) mode using positive ionization with an m/z 553 for DNS-piperazine-DNS and m/z 320 for DNS-Cl monosubstituted derivative (DNS-piperazine). Nitrogen was used as the sheath, auxiliary, and ion sweep gas. Spray pressure was applied at 40 psi, drying gas flow was 10 mL/min, drying gas temperature was set at 350 C, and collision energy was 70 V.
Preparation of standards and samples
A standard stock solution of piperazine was prepared by weighing 11.75 mg of piperazine standard in 10 mL of water using a 10 mL volumetric flask, transferring 100 μL of this solution to an individual 10 mL volumetric flask, and diluting to volume with water to give a concentration of 11.75 μg mL -1 of piperazine. The required concentrations were then prepared by serial dilution in water.
The standard stock solution was permanently stored at 4 C and diluted as needed to an appropriate concentration with water to give intermediate concentrations equivalent to 35.25, 58.75, 94, 117.5, 141, and 235 ng mL -1 of piperazine. Carbonate buffer (pH 10.0) was prepared by mixing 0.1 mol/L sodium carbonate solution with 0.1 mol/L sodium bicarbonate solution (5/4, v/v). The sodium carbonate solution was prepared by weighing 1.06 g of sodium carbonate in 100 mL water. The sodium bicarbonate solution was prepared by weighing 0.84 g of sodium bicarbonate in 100 mL water.
The DNS-Cl reagent was freshly prepared by dissolving 100 mg in 100 mL acetonitrile to give a concentration of 1 μg mL -1 . The DNS-Cl reagent was stored at 4 C and protected from light.
A sample solution of VT was prepared by weighing 20 mg of VT into a 10 mL volumetric flask, dissolving the solution in 7 mL of acetonitrile and 350 μL of 0.1 mol/L NaOH by 30 s of ultrasonication, and diluting with acetonitrile to a concentration of 2 mg mL -1 .
Preparation of derivatization solutions
The test solutions were prepared by transferring 200 μL of carbonate buffer (pH 10.0), 100 μL tested solution (e.g., standard stock solution of piperazine, sample solution, or system suitability solution), 100 μL of acetonitrile, and 600 μL of DNS-Cl to a 1.5-mL centrifuge tube. The mixture was vortexed for 20 s and incubated in a water bath at 50 C for 30 min, and protected from light. Next, the mixture was cooled to room temperature, transferred to an individual 10 mL volumetric flask, and diluted to volume with acetonitrile.
The derivative of blank solution was prepared with the same approach as the test solutions only needed changing 100 μL tested solution into 100 μL water.
Method validation
The method was validated according to ICH guidelines. 27 System suitability tests were used to investigate whether the symmetry, resolution, and repeatability of the chromatographic peaks were adequate for the required analysis. System suitability was evaluated in six samples of identical concentrations of piperazine (1.175 ng mL -1 ) and VT (20 μg mL -1 ) solutions. The LOD and LOQ were calculated based on signal-to-noise ratio by injecting a series of diluted solutions of known concentrations. The LOD was defined as the concentration of the analyte at a signal-to-noise (S/N) ratio of 3, and the LOQ was defined as an S/N ratio of 10.
Linearity of piperazine was evaluated based on linear regression analyses of a calibration curve using six concentrations (0.3525, 0.5875, 0.94, 1.175, 1.41, and 2.35 ng mL -1 ). The calibration curve was obtained by plotting the area under the peak (AUP) against concentration (C).
Accuracy was assessed through the recovery of piperazine by adding three different concentrations of piperazine standard solution, of low, medium, and high concentration, to VT standards.
The resulting relative amounts of piperazine standards in VT (20 μg mL of VT, were tested by the same analyst on the same day. In addition, the samples were analyzed on the following day using the same procedure. Seven parameters were modified to evaluate the robustness of the LC-MS method for piperazine detection: drying gas flow was adjusted ±10%; spray pressure was adjusted ±5 psi; collision energy was adjusted ±10 V; flow rate of the mobile phase was adjusted ±10%; column temperature was changed ±5 C; and content of formic acid in the mobile phase was adjusted ±0.03%.
In addition, columns from different manufacturers were used.
The stability of standard solutions and sample solutions was evaluated by placing these solutions at room temperature for 12 h, protected from light, before performing the experimental procedure and observing whether any change occurred in the chromatographic pattern, compared with freshly prepared solutions.
Results and Discussion
LC-MS method development
During the optimization process, several columns were evaluated, and the C8 column produced the best results with good peak intensity, sharp peaks with enhanced resolution, and high throughput elution. A Phenomenex Luna C18 column (50 × 2.0 mm, 5 μm 100 A) with 0.1% formic acid and acetonitrile as mobile phase was used at a flow rate of 0.5 mL/min in isocratic mode for the determination of piperazine starting condition. Because of the strong polarity of piperazine, it was not retained under reverse phase chromatography. DNS-Cl derivatization, however, increased piperazine retention under reversed phase chromatographic conditions. 13 Because the polarity of the piperazine derivative was subsequently lower, a C18 column could be used for the separation of piperazine. 13, 18 The retention of the VT derivative was stronger in the C18 chromatographic column, and elution was more difficult. Moreover, the symmetry of the piperazine derivative peak was poorer and the theoretical plate number was fewer using the C18 column. In order to shorten and rationalize the analysis time for the derivatives of piperazine and VT, a C8 column was chosen for the experiments. Waters SunFire C8 (150 × 4.6 mm, 3.5 μm), Phenomenex Luna C8 (150 × 4.6 mm, 3 μm), and Waters XBridge C8 (150 × 4.6 mm, 3.5 μm) chromatographic columns were used to screen the derivatives. All of the above C8 chromatographic columns tested seemed to meet the detection requirements for piperazine derivatives, with tailing factors in the range 0.9 -1.1. However, Waters SunFire C8 columns are used for general purpose method development at low pH. This C8 ligand is preferred for some assays, and because it is less hydrophobic, there was less retention compared to Phenomenex Luna C8. In addition, the Waters SunFire C8 column provided an excellent peak shape of piperazine, with a tailing factor of 1.00. The number of theoretical plates of piperazine on SunFire C8 column was 41320, which was much higher than for the other two. Waters Xbridge C8 columns are more suitable for the separation of basic compounds with a wide range of pH values, but the column pressure was much higher (184 bar) than the two other columns, though a good peak shape of piperazine was obtained. Therefore, Waters SunFire C8 column was chosen as the final stationary phase.
Sodium chloride, hydrobromide, and magnesium sulfate salts were used in the process for the synthesis of VT, and their residues may be present in the final product. In addition, small amounts of relative substances were found in VT. 2, 4 The structures of relative substances were similar to VT, which could also react with DNS-Cl and produce some compounds with molecular weight similar to the analyte. These substances above could be dissolved by the solvent and coexist with the test sample. When the sample was directly introduced into MS, matrix effects might be induced that interfere with the quantitation of piperazine. Matrix effects can be eliminated by optimizing reverse phase chromatographic conditions to separate analytes from endogenous impurities.
Given that the derivatization reaction reduces the polarity of the compounds, acetonitrile, with its strong eluting capacity, was preferred as the mobile phase. At the same time, considering that piperazine and VT derivatives are alkaline compounds, 0.1% formic acid was used to improve the symmetries of piperazine and VT derivative peaks.
DNS-Cl can react with the primary or secondary amines of piperazine to replace sulfonyl and produce sulfamide. The monomolecular HCl is removed so as to produce the derivative under UV light, known as the amine sulfonylation reaction. Lin et al. obtained a piperazine monosubstituted derivative with DNS-Cl by using this principle. 18 The derivative path is shown through response Eq. (1) in Fig. 1 . In this study, monosubstituted and disubstituted piperazine were evaluated to confirm the precolumn derivatization reaction. The mass spectrum of each target ion at each time point was obtained by extracting m/z 552.7 -553.7 and 319.7 -320.7 target ions. Meanwhile, the primary and secondary derivatives of piperazine were monitored. The results showed that piperazine could react completely with bimolecular DNS-Cl under the selected derivatization reaction conditions, namely through response Eq. (2) in Fig. 1 . The spectrum is shown in Fig. 2A , and the quantitative ion 553 was selected. Because a secondary amine existed in the VT structure, it also could occur in the amine sulfonylation reaction with DNC-Cl under the selected condition. The derivative path is shown through response Eq. (3) in Fig. 1 . The spectrum is shown in Fig. 2B , and the quantitative ion 532 was selected.
The solubility of VT was poor in water, acetonitrile, ethanol, tetrahydrofuran, and ethyl acetate, although it was soluble in methanol. Therefore, initially methanol was chosen as the solvent. However, it was found that methanol could react with the derivatization reagent to interfere with the determination of analytes, as shown in the spectrum in Fig. 3 . Although Lin et al. used methanol to dissolve the internal standard substance in previous work, 18 in this study, 20 mg of test sample was dissolved in 7 mL acetonitrile, the solution was vortexed, and 350 μL 0.1 mol/L NaOH solution was slowly added so as to better dissolve VT. Acetonitrile and NaOH cannot react with the derivatization reagents and, therefore, did not interfere with analyte determination.
System suitability testing of the RP-HPLC method
The symmetry, resolution, and repeatability of the chromatographic peaks were assessed using system suitability tests. Repeatability and symmetry factors show the accuracy of quantitative analysis, and resolution can be used to confirm that closely eluting compounds are resolved from each other. Different parameters affecting chromatographic separation were studied, including column efficiency (number of theoretical plates), tailing factor, percentage relative standard deviation (%RSD) of the peak area, and retention time of six injections, as shown in Table 1 . The chromatogram is shown in Fig. 4 .
Method validation
The LOD of piperazine was at a concentration of 0.1175 ng mL -1 (S/N = 3.5), which was equivalent to 5.88 μg g -1 of VT (20 μg mL -1 ). The LOQ of piperazine was at a concentration of 0.3525 ng mL -1 (S/N = 10.8), which was equivalent to 17.62 μg g -1 of VT (20 μg mL -1 ). Sensitivity was higher than that of the literature (LOD of HPLC-DAD was 0.012 μg/mL, 17 HPLC-ELSD was 10 μg/mL, 14 and GC was 3 ng/mL and 50 μg/mL).
12,16
Low LOD and LOQ values indicate high sensitivity in the applied method for determination of piperazine in VT.
Specificity is the ability of an analytical method to measure the analyte response in the presence of interference sources, including other substances. In the present study, specificity was evaluated by analyzing the retention time of the piperazine monosubstituent, piperazine disubstituent, and VT.
No interferences were observed at the retention time of piperazine disubstituent and VT. Piperazine monosubstituent was not detected under the selected derivatization conditions (Fig. 4) .
In this study, a linear relationship between the area AUP and the component concentration (C) was obtained using six chosen concentrations, and a regression equation was then computed for the chromatographic method. The regression coefficient r was 0.9994, and the regression equation was AUP = 4275.5Cng/mL -463.43, indicating excellent linearity over the piperazine concentration range of 0.3525 -2.35 ng mL -1 , which was equivalent to 17.625 -117.5 μg g -1 of VT (20 μg mL -1 ).
Accuracy was assessed in VT spiked with known amounts of piperazine. The accuracy of the results was calculated using the %recovery for three different concentrations of each component. The percentage of mean recoveries of piperazine was obtained in the range of 93.6 -100.5% (n = 9, RSD% = 2.3), indicating high accuracy of the method.
Repeatability was evaluated based on the similarity between concentration levels of six replicates of a 1.175 ng mL -1 piperazine derivative that was added to a VT derivative (20 μg mL -1 ) and assessed on the same day, using the procedure described in Experimental section.
The %RSD (n = 6, RSD% = 1.7) of piperazine was calculated and found to be less than 2% using the same concentrations, indicating good repeatability of the method. The aforementioned concentrations were analyzed on the following day using the procedure mentioned above. Intermediate precision was evaluated by calculating the amounts of RSD of piperazine on the prior day and the following day. The %RSD (n = 12, RSD% = 3.4) of piperazine was calculated and found to be less than 3.5%, indicating good precision of the method.
Robustness was investigated by deliberately modifying the analytical parameters. Known amounts of piperazine were spiked in VT samples. The most important criterion evaluated was the amount of piperazine detected in VT in different analytical parameter conditions. As shown in Table 2 , the changes of analytical parameter did not affect the amount of piperazine detected in VT. There was no significant difference in the results obtained for all variations, indicating good robustness of the proposed LC-MS method.
Stability of the system suitability solution and standard solution of piperazine was evaluated after 12 h at room temperature. Good stability was observed under the test conditions.
Determination of piperazine in VT
For these studies, five batches of VT bulk drug were prepared under the same conditions, and each sample was analyzed in triplicate using HPLC.
Piperazine was found to be 0.1639 ng mL -1 (n = 3, RSD% = 1.76) in one batch of VT bulk drug, which was equivalent to 8.2 μg g -1 of VT (20 μg mL -1 ). None of the other four batches of bulk drug contained the target analyte at the detectable concentrations (0.1175 ng mL -1 ).
Conclusions
A highly sensitive LC-MS method, coupled with precolumn derivatization with DNS-Cl, was established for the quantitation of piperazine trace residues in VT. The separation of piperazine and its APIs using a C8 column is reported here for the first time. The LOD was 0.1175 ng mL -1 . The total run time on the C8 column was 10 min, the tailing factor was within the range 0.9 -1.1, and the number of theoretical plates was >20000, a duration suitable for daily quality control purposes. Piperazine derivatization types were evaluated in the presence of DNS-Cl monosubstituted and disubstituted derivatives. The method was validated for specificity, LOQ, LOD, linearity, precision, accuracy, and robustness. Based on the validation results, the LC-MS method developed was considered suitable for the quantitation of piperazine residues in VT. 
